Lv5
1100 积分 2022-04-11 加入
Comparative effectiveness of inebilizumab versus conventional immunotherapies in AQP4-IgG-positive NMOSD: a prospective cohort study with time-varying treatment effects
3天前
已完结
Inebilizumab Monotherapy in Relapsing IgG4-Related Tubulointerstitial Nephritis
4天前
已完结
Dalmelitinib Plus Aumolertinib in Advanced NSCLC Patients With EGFR-TKI Resistance and MET Amplification: A Randomized Phase 3 Trial
4天前
已完结
Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection
11天前
已完结
In chronic HBV infection receiving nucleos(t)ide therapy, bepirovirsen vs. placebo increased treatment-free functional cure at 72 wk
11天前
已关闭
皖公网安备34019202002308
